Universal Remedy: Toxin Treatments

Toxin treatments were first introduced into clinical practice in the 1980s when ophthalmologists began injecting them into humans. Their use in the cosmetic field was first reported in 1992 for the treatment of glabellar wrinkles. In 1991, Allergan purchased a small toxin-producing company for $9 million. With the rise in cosmetic applications and its status as the most commonly performed aesthetic procedure today, Allergan earned $2.45 billion from toxin treatments in 2015 alone.

Currently, injections into the glabellar muscles remain the most common area for toxin treatments, but it can also be applied to all facial muscles in varying doses. Beyond cosmetic applications, toxin treatments are also successfully used in the treatment of migraine headaches. Neurologists work with appropriately selected patients to achieve significant benefits from this treatment.

In cases of excessive sweating in the hands and feet, intradermal toxin treatments can reduce sweating for up to six months.

Toxin treatments performed by individuals who lack medical training and anatomical knowledge can result in unnatural facial appearances and asymmetries at the very least.